Role of weight-based ribavirin dosing and extended duration of therapy in chronic hepatitis C in HIV-infected patients: the PRESCO trial (Q43040301)
Jump to navigation
Jump to search
scientific article published in August 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Role of weight-based ribavirin dosing and extended duration of therapy in chronic hepatitis C in HIV-infected patients: the PRESCO trial |
scientific article published in August 2007 |
Statements
1 reference
Role of weight-based ribavirin dosing and extended duration of therapy in chronic hepatitis C in HIV-infected patients: the PRESCO trial (English)
1 reference
Vincent Soriano
1 reference
Victor Asensi
1 reference
Marina Núñez
1 reference
Celia Miralles
1 reference
Miguel Angel Berdún
1 reference
Elena Losada
1 reference
Koldo Aguirrebengoa
1 reference
Antonio Ocampo
1 reference
Piedad Arazo
1 reference
Manuel Cervantes
1 reference
Ignacio de Los Santos
1 reference
Isabel San Joaquín
1 reference
Santiago Echeverría
1 reference
María José Galindo
1 reference
Pablo Barreiro
1 reference
Julio Sola
1 reference
Juan José Hernandez-Burruezo
1 reference
Josep Maria Guardiola
1 reference
Miriam Romero
1 reference
Javier García-Samaniego
1 reference
PRESCO Study Group
1 reference
1 August 2007
1 reference
1 reference
Identifiers
1 reference